Baseline Characteristics of Patients with Relapsed or Refractory Non-Hodgkin's Lymphoma in a Phase I Trial of Puquitinib Mesylate (XC-302, an inhibitor of phosphatidylinositol 3-kinase p110δ). The gene discussed is PIK3CD; the disease is non-Hodgkin lymphoma.